News Daily News European Societies Define Best Practices for Performing Renal Denervation Todd Neale February 21, 2023
News Daily News Longer-Term ASCVD Risk Assessment Best for Younger Patients Michael O'Riordan February 16, 2023
News Daily News Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories Caitlin E. Cox February 10, 2023
News Daily News Autism and Cardiometabolic Disease Often Go Hand in Hand Caitlin E. Cox February 06, 2023
News Daily News Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals L.A. McKeown February 06, 2023
News Daily News BP Reduction With Renal Denervation Still Evident a Decade On Michael O'Riordan January 31, 2023
News Daily News More Frequent, Longer Movement Breaks Can Attenuate Harms of Sitting Yael L. Maxwell January 13, 2023
News Daily News Meeting WHO’s Sodium Benchmarks Would Cut Deaths, Illness, Model Suggests L.A. McKeown January 10, 2023
News Daily News Gay Men, Bisexual Women Face Unique Hypertension Risks Caitlin E. Cox January 03, 2023
News Daily News Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds L.A. McKeown December 29, 2022
News Daily News Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis Todd Neale December 23, 2022
News Daily News ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly L.A. McKeown December 22, 2022
News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements Michael O'Riordan December 07, 2022
News Daily News Think Before You Shake: UK Biobank Data Link Added Salt to Long-term CVD Risks L.A. McKeown November 30, 2022
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Daily News Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results Todd Neale November 16, 2022